Clinical TrialsKelun-Biotech Reports Positive Phase III OptiTROP-Lung06 Results in NSCLC Kelun-Biotech Reports Positive Phase III OptiTROP-Lung06 Results in NSCLC Read Post »
Health TidingsApnimed’s AD109 NDA Accepted by FDA for Obstructive Sleep Apnea Apnimed’s AD109 NDA Accepted by FDA for Obstructive Sleep Apnea Read Post »
Health TidingsFDA Grants Priority Review to Roche’s Gazyva/Gazyvaro for Adults with Pri... FDA Grants Priority Review to Roche’s Gazyva/Gazyvaro for Adults with Pri... Read Post »
Clinical TrialsJAMA Publishes Phase 2 Ceperognastat Trial Results in Early Alzheimer’... JAMA Publishes Phase 2 Ceperognastat Trial Results in Early Alzheimer’... Read Post »
New Drug ApprovalFDA Grants Full Approval to Retevmo for RET Fusion-Positive Solid Tumors Ac... FDA Grants Full Approval to Retevmo for RET Fusion-Positive Solid Tumors Ac... Read Post »
GenericsFDA Approves First Generic Afatinib Tablets for EGFR-Mutated NSCLC FDA Approves First Generic Afatinib Tablets for EGFR-Mutated NSCLC Read Post »
New Drug ApprovalFDA Approves REVTORPYK for PIK3CA Wild-Type HR+/HER2- Advanced Breast Cance... FDA Approves REVTORPYK for PIK3CA Wild-Type HR+/HER2- Advanced Breast Cance... Read Post »
Clinical TrialsMediPharm Reports Positive Phase 2 LiBBY Results for Oral Cannabinoid Thera... MediPharm Reports Positive Phase 2 LiBBY Results for Oral Cannabinoid Thera... Read Post »
Health Tidings Regulatory & Health PolicyFDA Releases First Psychedelic Drug Development Guidance FDA Releases First Psychedelic Drug Development Guidance Read Post »
Clinical TrialsBiogen Advances Diranersen to Phase 3 After Positive CELIA Data Biogen Advances Diranersen to Phase 3 After Positive CELIA Data Read Post »
Clinical TrialsImmutep Reports 30.9-Month Overall Survival in Phase I INSIGHT-003 Trial of... Immutep Reports 30.9-Month Overall Survival in Phase I INSIGHT-003 Trial of... Read Post »
Clinical TrialsHemab Reports Durable Phase 2 Results for Sutacimig in Glanzmann Thrombasth... Hemab Reports Durable Phase 2 Results for Sutacimig in Glanzmann Thrombasth... Read Post »
Clinical TrialsDefinium Study Shows High Treatment Discontinuation in Generalized Anxiety ... Definium Study Shows High Treatment Discontinuation in Generalized Anxiety ... Read Post »
Health TidingsSummit Sells Phase III Antibiotic Ridinilazole to Biossil in Up to $105 Mil... Summit Sells Phase III Antibiotic Ridinilazole to Biossil in Up to $105 Mil... Read Post »
Health Tidings Mergers & AcquisitionsNovartis Partners With Chai Discovery to Advance AI Antibody Discovery Novartis Partners With Chai Discovery to Advance AI Antibody Discovery Read Post »
Health Tidings Mergers & AcquisitionsSpero Secures Global Rights to Innovent’s Anti-CD40L Antibody IBI355 in U... Spero Secures Global Rights to Innovent’s Anti-CD40L Antibody IBI355 in U... Read Post »
Health Tidings Mergers & AcquisitionsAstraZeneca Licenses Zegfrovy from Dizal in Up to $1.5 Billion Deal to Expa... AstraZeneca Licenses Zegfrovy from Dizal in Up to $1.5 Billion Deal to Expa... Read Post »
Clinical TrialsEisai Presents Findings Showing Etalanetug Reduced Alzheimer’s Tau Ta... Eisai Presents Findings Showing Etalanetug Reduced Alzheimer’s Tau Ta... Read Post »
Health Tidings Mergers & AcquisitionsIndonesia Grants Takeda Plasma Fractionation License for PDMP Production Indonesia Grants Takeda Plasma Fractionation License for PDMP Production Read Post »
Clinical TrialsOncolytics Advances Pelareorep Toward Registration in Metastatic Colorectal... Oncolytics Advances Pelareorep Toward Registration in Metastatic Colorectal... Read Post »
Health TidingsAgenus Secures $340M to Advance ROBBIN Trial of Botensilimab + Balstilimab ... Agenus Secures $340M to Advance ROBBIN Trial of Botensilimab + Balstilimab ... Read Post »
New Drug ApprovalFDA Approves Weekly LEQEMBI IQLIK Autoinjector for At-Home Initiation of Ea... FDA Approves Weekly LEQEMBI IQLIK Autoinjector for At-Home Initiation of Ea... Read Post »
Health TidingsArmata Receives FDA Agreement on Pediatric Study Plan for AP-SA02 Armata Receives FDA Agreement on Pediatric Study Plan for AP-SA02 Read Post »
Health TidingsBioMarin’s VOXZOGO sNDA Accepted by FDA for Full Approval in Children wit... BioMarin’s VOXZOGO sNDA Accepted by FDA for Full Approval in Children wit... Read Post »
Clinical TrialsANI Reports Positive Results for ILUVIEN in Chronic Posterior Uveitis ANI Reports Positive Results for ILUVIEN in Chronic Posterior Uveitis Read Post »
Health TidingsIpsen Reports Positive Phase IIIb Results for IQIRVO in PBC Ipsen Reports Positive Phase IIIb Results for IQIRVO in PBC Read Post »
Health TidingsLongeveron Reports New Phase 2a Data Showing Laromestrocel Reduced Brain In... Longeveron Reports New Phase 2a Data Showing Laromestrocel Reduced Brain In... Read Post »
Health TidingsLatarcibart Reduces Annual Bleeding Rate by 81% in Phase 1/2 Study of Von W... Latarcibart Reduces Annual Bleeding Rate by 81% in Phase 1/2 Study of Von W... Read Post »
Clinical TrialsCadrenal Reports Phase 2 CAD-1005 Data Showing Reduced Thrombotic Events in... Cadrenal Reports Phase 2 CAD-1005 Data Showing Reduced Thrombotic Events in... Read Post »
Clinical TrialsHemab Reports Positive HMB-002 Results, Introduces HMB-003 at ISTH 2026 Hemab Reports Positive HMB-002 Results, Introduces HMB-003 at ISTH 2026 Read Post »
Clinical TrialsAlixorexton Shows Sustained Wakefulness and Daytime Sleepiness Benefits for... Alixorexton Shows Sustained Wakefulness and Daytime Sleepiness Benefits for... Read Post »
Health TidingsLongBio Pharma Wins FDA IND Clearance for LP-003 Peanut Allergy Trial LongBio Pharma Wins FDA IND Clearance for LP-003 Peanut Allergy Trial Read Post »
Health TidingsMezigdomide NDA Accepted After Phase 3 Trial Doubled Progression-Free Survi... Mezigdomide NDA Accepted After Phase 3 Trial Doubled Progression-Free Survi... Read Post »
Health TidingsOxford Launches First Phase I Bundibugyo Ebola Vaccine Trial Oxford Launches First Phase I Bundibugyo Ebola Vaccine Trial Read Post »
Clinical TrialsQ32 Bio Reports Positive Phase 2 Results for Bempikibart in Alopecia Areata Q32 Bio Reports Positive Phase 2 Results for Bempikibart in Alopecia Areata Read Post »
Clinical TrialsGSK’s Jemperli Phase II Trial Shows Durable Complete Responses in dMMR Re... GSK’s Jemperli Phase II Trial Shows Durable Complete Responses in dMMR Re... Read Post »
Clinical TrialsLifestyle Intervention Improves Cognitive Function in Older Adults at Risk ... Lifestyle Intervention Improves Cognitive Function in Older Adults at Risk ... Read Post »
Clinical TrialsAAIC 2026: Subcutaneous LEQEMBI Matches IV Therapy in Early Alzheimer’... AAIC 2026: Subcutaneous LEQEMBI Matches IV Therapy in Early Alzheimer’... Read Post »
Clinical TrialsIN8bio Publishes Phase 1 INB-200 Glioblastoma Data in JCO Showing Survival ... IN8bio Publishes Phase 1 INB-200 Glioblastoma Data in JCO Showing Survival ... Read Post »
Clinical TrialsNovo Nordisk Reports Positive Results for Denecimig and Concizumab Novo Nordisk Reports Positive Results for Denecimig and Concizumab Read Post »
Clinical TrialsAB Science Discontinues Three Masitinib Trials to Prioritize ALS Phase III ... AB Science Discontinues Three Masitinib Trials to Prioritize ALS Phase III ... Read Post »
Drugs Safety AlertJAMA Explores Evidence Behind HHS Proposed Testosterone Label Revisions JAMA Explores Evidence Behind HHS Proposed Testosterone Label Revisions Read Post »
ManufacturingMHRA Approves UK Plasma Manufacturing for Five High-Priority Medicines MHRA Approves UK Plasma Manufacturing for Five High-Priority Medicines Read Post »
Health Tidings Mergers & AcquisitionsSino Biopharma Secures China Rights to GSK’s Trelegy and Anoro Sino Biopharma Secures China Rights to GSK’s Trelegy and Anoro Read Post »
ResearchNew Study Challenges Autism Concerns Over Acetaminophen Use During Pregnanc... New Study Challenges Autism Concerns Over Acetaminophen Use During Pregnanc... Read Post »
Health TidingsFDA Issues Complete Response Letter for Elevar’s Rivoceranib Plus Cam... FDA Issues Complete Response Letter for Elevar’s Rivoceranib Plus Cam... Read Post »
New Drug ApprovalFDA Approves Merck’s Keytruda Plus Pfizer-Astellas’ Padcev for ... FDA Approves Merck’s Keytruda Plus Pfizer-Astellas’ Padcev for ... Read Post »
Clinical TrialsBausch + Lomb Discontinues BL1107 Eye Drops Following Phase 2 Glaucoma Fail... Bausch + Lomb Discontinues BL1107 Eye Drops Following Phase 2 Glaucoma Fail... Read Post »
Health TidingsSino Files TQB3454 NDA in China for IDH1-Mutant Biliary Tract Cancer Sino Files TQB3454 NDA in China for IDH1-Mutant Biliary Tract Cancer Read Post »
Health TidingsArialys Therapeutics Receives FDA Fast Track Designation for ART5803 in Ant... Arialys Therapeutics Receives FDA Fast Track Designation for ART5803 in Ant... Read Post »
